The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Athiya Agarwal
AGARWALEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
BSE has received a disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, filed by Dr. Athiya Agarwal, who is part of the promoter family of Dr. Agarwals Health Care Ltd. Regulation 29(2) requires continual disclosure whenever a person's shareholding changes by more than 2% of the company's total share capital. The filing signals a notable change in Dr. Athiya Agarwal's equity stake in the company, though the specific direction (acquisition or disposal), the number of shares involved, and the resulting shareholding percentage are not detailed in the headline.
This is a routine regulatory disclosure by a member of the promoter group indicating a material change in their shareholding. Shareholders should look for the detailed filing to understand whether this represents a buy or sell, and whether it alters the overall promoter holding of the company.